Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04091386 · ClinicalTrials.gov registry record
Study to Learn More About the Physical Activity Level of Patients Suffering From Hemophilia A Treated With Damoctocog Alfa Pegol (LIFE ACTIVE Study)
A clinical trial of Hemophilia A, sponsored by Bayer.
- Completed
- Registry status
- 10
- Enrollment target
- 8
- Study locations
NCT04091386: Completed study of Hemophilia A, sponsored by Bayer.
NCT04091386 is a study of Hemophilia A that has completed, run by Bayer. The registered enrollment target is 10 participants, below the 91-participant average among 42 other Hemophilia A trials with a reported enrollment target (89% lower). The trial reports 8 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04091386, a study of Hemophilia A, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
- 8
- Study locations
Study Summary
In this study researcher want to learn more about the change of physical activity of hemophilia A patients treated with damoctocog alfa pegol. Patients enrolled in this study will be wearing a small device measuring daily active time. Researcher will compare these physical activity data with patient's clinical data including bleeding events to gain information on how bleeding levels are related to the activity level of the patients. The study aims to enroll about 80 patients who are at the same time also participating in the HEM-POWR study (NCT03932201) evaluating the effectiveness and safety of damoctocog alfa pegol.
Conditions Studied
Interventions
- DRUG Damoctocog alfa pegol (Jivi, BAY94-9027)
Study Locations (8)
Other
- Many Locations - Multiple Locations
- Many Locations - Multiple Locations
- Many Locations - Multiple Locations
- Many Locations - Multiple Locations
- Many Locations - Multiple Locations
- Many Locations - Multiple Locations
California
- Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders - Orange
Louisiana
- Tulane University - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-06-10 |
| Est. Completion | 2024-07-05 |
What the finished NCT04091386 record still lists
NCT04091386 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 91-participant average among 42 other Hemophilia A trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Hemophilia A appearing as the primary indexed condition, and to 1 intervention - of which Damoctocog alfa pegol (Jivi, BAY94-9027) is the first listed.
NCT04091386 lists 8 locations in 3 states (Other, California, Louisiana).
Frequently Asked Questions
What is clinical trial NCT04091386 about?
NCT04091386 is a clinical study titled "Study to Learn More About the Physical Activity Level of Patients Suffering From Hemophilia A Treated With Damoctocog Alfa Pegol (LIFE ACTIVE Study)". In this study researcher want to learn more about the change of physical activity of hemophilia A patients treated with damoctocog alfa pegol. Patients enrolled in this study will be wearing a small device measuring daily active time. Researcher will compare these physical activity data with patient...
What is the current status of trial NCT04091386?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2021-06-10. Estimated completion is 2024-07-05.
What conditions does trial NCT04091386 study?
This clinical trial studies the following conditions: Hemophilia A.
What interventions are being tested in trial NCT04091386?
The interventions under investigation include: Damoctocog alfa pegol (Jivi, BAY94-9027) (DRUG).
Who is sponsoring clinical trial NCT04091386?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04091386 being conducted?
This trial has 8 study locations across California, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemophilia A
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04091386's enrollment target sits among peer trials
10 38th of 42 higher than 5 of 42 other Hemophilia A trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hemophilia A trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
RECRUITING · Phase 3
-
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
RECRUITING · Phase 3
-
A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
RECRUITING · Phase 1
-
Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
RECRUITING · Phase 4
-
Hemophilia A Research Program
RECRUITING
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI